MONTREAL, QUEBEC -- (MARKET WIRE) -- September 28, 2006 -- IBEX Technologies Inc. (TSX: IBT), an innovator in the development of diagnostics for the management of cancer and arthritis, and a supplier of high-purity glycobiology enzymes, today reported its financial results for the fourth quarter and fiscal year ended July 31, 2006.
